Our technology platforms allow us to study human disease and develop therapeutics on a personalized level. Physiological models can be personalized using organ-on-a-chip and advanced computational methods such as machine learning and deep learning. Therapeutics can be personalized using devices with sensors to deliver what is needed when it is needed. Damaged organs and tissues can be addressed with personalized transplants using biomaterials that are three-dimensionally printed.